ArticleAmerican journal of ophthalmology2008

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence.

John H Kempen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.